Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04347473 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT04347473 · ClinicalTrials.gov record · last posted 2020-04-15

ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.

Name: ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis. — clinical trial record (NCT04347473)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorPsoriasis Treatment Center of Central New Jersey

Started2020-04-06

View on ClinicalTrials.gov ↗

Record status

This record was last updated April 15, 2020 (before its estimated December 30, 2020 completion). Its status may not reflect the trial's current state.

from the ClinicalTrials.gov record

Patient with moderate-to-severe plaque psoriasis will receive Ilumya with or without Halog ointment.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2020-04-13. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-03-14

Status change Recruiting→Completedv1

Trial Details

NCT Number	NCT04347473
Lead Sponsor	Psoriasis Treatment Center of Central New Jersey Collaborators: Sun Pharmaceutical Industries Limited
Conditions	Psoriasis
Enrollment	25 participants
Start Date	2020-04-06
Primary Completion	2020-12-30 (estimated)
Study Completion	2021-03-01 (estimated)
Updated on ClinicalTrials.gov	2020-04-15